SYRE compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SYRESpyre Therapeutics, Inc.

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SYRE: latest quarter not drawable.Method ›

Price

rebased to 0%

SYRE, solidTNGX, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SYRE 5

—WuXi Biologics (Hong Kong)unlistedsupplier

—Paragonunlistedsupplier

—WuXi Biologicsunlistedsupplier

—Equiniti Trust Company LLC (f/k/a American Stock Transfer & Trust Company LLC)unlistedsupplier

1 more · SYRE chain ›

Shared 0

No shared counterparties.

Only TNGX 1

—WuXi AppTecunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

Mkt cap$8.5BRevenue—Revenue—

TNGXTango Therapeutics, Inc.

22.72▲+0.84%· post 22.72

ClosedOct 30 '26

Mkt cap$3.8BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

ClosedOct 30 '26

SYRESpyre Therapeutics, Inc.

TNGXTango Therapeutics, Inc.

96.44▼−2.55%

Price

22.72▲+0.84%post 22.72

$8.5B

Mkt cap

$3.8B

—

Revenue

$54MQ3 FY25

—

Revenue

$42MFY24

SYRE96.44▼−2.55%vsTNGX22.72▲+0.84%ClosedOct 30 '26